Supplier Product Identification Physical and Chemical Properties First Aid Measures Handling and Storage Hazards Identification Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity
Home > Diethylene glycol dimethacrylate > Diethylene glycol dimethacrylate(2358-84-1)

Diethylene glycol dimethacrylate(2358-84-1)

Supplier Product Identification Physical and Chemical Properties First Aid Measures Handling and Storage Hazards Identification Exposure Controls/Personal Protection Fire Fighting Measures Accidental Release Measures Stability and Reactivity
More
Less

Product Identification

Product Name

Diethylene glycol dimethacrylate

Synonyms

2-[2-(2-Methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate
Diethylene glycol dimethacrylate
Oxydi-2,1-ethanediyl bismethacrylate
Oxydiethylene methacrylate
TGM 2

CAS

2358-84-1

Formula

C12H18O5

Molecular Weight

242.27

EINECS

219-099-9

Beilstein/Gmelin

1789727

Beilstein Reference

4-02-00-01531

More
Less

Physical and Chemical Properties

Appearance

Colorless liquid. Ester-like odor.

Boiling Point

82 - 84 (0.04 torr)

Density

1.07 g/cm3 (20 C)

Usage

Crosslinked acrylicvinyl resin comonomer.

Refractive Index

1.4571 (25 C)

More
Less

First Aid Measures

Ingestion

Administer charcoal as a slurry (240 ml water/30 g charcoal). Usual dose: 25 to 100 g in adults/adolescents.

Inhalation

Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.

Skin

Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists. Some chemicals can produce systemic poisoning by absorption through intact skin. Carefully observe patients with dermal exposure for the development of any systemic signs or symptoms and administer symptomatic treatment as necessary.

Eyes

Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.

More
Less

Handling and Storage

Storage

Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.

Handling

All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.

More
Less

Hazards Identification

Inhalation

Death normally occurs from sudden cardiorespiratory arrest. Pulmonary edema may develop. Tachypnea may occur secondary to acidosis.

Skin

Skin irritation, necrosis, and allergic contact dermatitis have been reported in workers.

Ingestion

Common initial symptoms are heartburn, followed by nausea and abdominal cramps, vomiting and occasionally diarrhea. Later symptoms include back pain and severe abdominal pain.

EC Risk Phrase

R 36/37/38

EC Safety Phrase

S 26 28

More
Less

Exposure Controls/Personal Protection

Personal Protection

Suitable protective clothing and self-contained resp protective apparatus should be available for use of those who may have to rescue persons overcome by fumes.

Respirators

Use NIOSH/MSHA approved respirator appropriate for exposure of concern.

Exposure Effects

Central nervous system depressant effects, including drowsiness, headache, progressive obtundation and coma have preceded death. Drowsiness is usually delayed approximately 24 hours after ingestion. Meningismus, cerebral edema and hemorrhage, and neuropathies have been reported. No human data were found at the time of this review with the exception of 1 case of menstrual irregularities from exposure to several acrylates. Animal studies at the time of this review did not show conclusive evidence of fetotoxicity or teratogenicity.

More
Less

Fire Fighting Measures

Flash Point

148

Fire Fighting

Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.

More
Less

Accidental Release Measures

Small spills/leaks

Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.

More
Less

Stability and Reactivity

Stability

No data.

Incompatibilities

Strong oxidizing agents.

More
Less

ContactMore

SUMMIT CHEMICAL
Tel
020-82567763
Qingdao RENAS Polymer Material Co.,Ltd.
Tel
0532-0532-86867058
Fax
0532-86867058
WebSite
http://www.qdrenas.com
Wuhan Rongcan Biotechnology Co., Ltd
Fax
183-27024450
WebSite
https://www.chemicalbook.com/ShowSupplierProductsList707052/0_EN.htm
J & K SCIENTIFIC LTD.
Tel
18210857532;
Fax
86-10-82849933
WebSite
https://www.jkchemical.com
MedicalChem(Yancheng)Manuf.Co.,Ltd
Tel
+86-515-84383180
Fax
+86-515-84383182
WebSite
http://www.medicalchemmanuf.com/